Category: Press Releases

Zoom Appoints Mike Fenger to Board of Directors

SAN JOSE, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) — Zoom Video Communications, Inc. (NASDAQ: ZM) announced that it has appointed Mike Fenger, vice president Worldwide Sales, Apple, as an independent director on Zoom’s Board of Directors effective immediately. “Zoom plays an important role connecting people around the world, and I’m

Continue Reading...

KEENON Robotics Showcases Innovative Smart Service Solutions with Embodied Intelligence at 2024 World Robot Conference

BEIJING, Aug. 26, 2024 (GLOBE NEWSWIRE) — KEENON Robotics presented its latest smart service solutions with embodied intelligence at the 2024 World Robot Conference, held at the Beijing Etrong International Exhibition and Convention Center, from 21-25 August 2024. This year’s conference, themed “Foster New Quality Productive Forces, Innovations for an

Continue Reading...

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Vicor Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – VICR

NEW YORK, Aug. 24, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Vicor Corporation (NASDAQ: VICR) between April 26, 2023 and February 22, 2024, both dates inclusive (the “Class Period”), of the important September 23, 2024 lead plaintiff

Continue Reading...

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages CrowdStrike Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CRWD

NEW YORK, Aug. 24, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A common stock of CrowdStrike Holdings, Inc. (NASDAQ: CRWD) between November 29, 2023 and July 29, 2024, both dates inclusive (the “Class Period”), of the important September 30,

Continue Reading...

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Bolt Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BOLT

NEW YORK, Aug. 24, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) between February 5, 2021 and May 14, 2024, both dates inclusive (the “Class Period”), of the important September 3, 2024 lead plaintiff

Continue Reading...